PathGroup, CCE Partner to Provide PGx Capabilities to Community-based Oncologists | GenomeWeb

NEW YORK (GenomeWeb) – PathGroup and Cancer Clinics of Excellence today announced a partnership aimed at improving the ability of community-based oncologists to make personalized therapeutic decisions.

CCE has chosen PathGroup as a preferred laboratory service provider, and oncologists in CCE's network will now have access to tests and data generated by PathGroup using its SmartGenomics platform, which generates information about patient drug targets so physicians can make more precise, personalized therapeutic recommendations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.